Considerable differences in the evaluation of global quality of life in primary breast cancer patients – Results in the control group of a randomized controlled trial
P Lindberg, W Lorenz, B Steinger, J Wyatt, F Hofstädter, M Klinkhammer-Schalke · DMW - Deutsche Medizinische Wochenschrift · 2012 · Heft 09
Bibliografische Angaben
Zusammenfassung
Introduction: Many breast cancer patients are affected by reduced quality of life (QoL). Problems often remain unrecognized. We investigated identification of diseased QoL by coordinating practitioners (CP). Method: Effectiveness of a QoL-pathway with QoL-diagnosis and therapy was investigated in an RCT with 199 primary breast cancer patients (intervention group (IG) n=99, control group (CG) n=100). All patients answered a QoL-questionnaire (EORTC QLQ-C30+BR23) during follow-up (0;3;6;9;12 months). CPs judged patients'global QoL as well. Diseased QoL was diagnosed below 50points (scale 0–100, very bad-very good)…
